Pelvic inflammatory disease. From diagnosis to prevention (Q37879336)

24 August 2017

1 reference

title

Pelvic inflammatory disease. From diagnosis to prevention (English)

1 reference

pelvic inflammatory diseases

24 August 2017

0 references

0 references

diagnosis

0 references

author name string

Paavonen J

series ordinal

1

1 reference

24 August 2017

1 October 1998

1 reference

24 August 2017

1 reference

24 August 2017

16

1 reference

24 August 2017

4

1 reference

24 August 2017

747-56, xii

1 reference

Survey of the treatment of Chlamydia trachomatis infection of the female genital tract

24 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Pelvic inflammatory disease and human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Clinical, laparoscopic and microbiological findings in acute salpingitis: report on a United Kingdom cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Morbidity following pelvic inflammatory disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Atypical pelvic inflammatory disease: can we identify clinical predictors?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Laparoscopy for the Confirmation and Prognostic Evaluation of Pelvic Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

The role of polymerase chain reaction and ligase chain reaction for the detection of Chlamydia trachomatis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Vaginal flora and pelvic inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Management of pelvic inflammatory disease by primary care physicians. A comparison with Centers for Disease Control and Prevention guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostic value of routine laparoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Plasma cell endometritis in women with symptomatic bacterial vaginosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: A double-blind, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Ectopic pregnancy falls in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Pelvic inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Oral contraception and the recognition of endometritis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Chlamydial pelvic inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Comparison of endometrial biopsy and peritoneal fluid cytologic testing with laparoscopy in the diagnosis of acute pelvic inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Prevalence and manifestations of endometritis among women with cervicitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Comparison of manual Amplicor PCR, Cobas Amplicor PCR, and LCx assays for detection of Chlamydia trachomatis infection in women by using urine specimens.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Noninvasive tests for diagnosis of Chlamydia trachomatis infection: application of ligase chain reaction to first-catch urine specimens of women

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

The accuracy of clinical findings and laparoscopy in pelvic inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Observations concerning the microbial etiology of acute salpingitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Diagnosis and laparoscopic grading of acute salpingitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Chlamydia trachomatis in the fallopian tubes of women without laparoscopic evidence of salpingitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Effect of Treatment Regimens forNeisseria gonorrhoeaeon Simultaneous Infection withChlamydia trachomatis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Role of bacterial vaginosis in pelvic inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

An audit of the management of pelvic inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Oral contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory disease. A word of caution about protection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Incidence, trends, and risks of ectopic pregnancy in a population of women

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970041-3

7 January 2021

10.1016/S0733-8635(05)70041-3

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

9891675